Robalzotan

DB06538ExperimentalSmall molecule

Investigated for use/treatment in anxiety disorders and depression.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 1A
Curator reviewed
Primary indication: Investigated for use/treatment in anxiety disorders and depression.Curator reviewed
Formula / weight: C₁₈H₂₃FN₂O₂ · 318.392 g/mol (avg)
Also known as: (R)-3-(Dicyclobutylamino)-8-fluoro-5-chromancarboxamide
Code names: AZD-7371 · NAD-299

Resolves to

Compound

Structure

InChIKeyMQTUXRKNJYPMCG-CYBMUJFWSA-NSMILESNC(=O)C1=C2C[C@H](COC2=C(F)C=C1)N(C1CCC1)C1CCC1

Targets

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Robalzotan, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.